Nutex Health Inc. (NASDAQ:NUTX) Stock Position Lessened by Renaissance Technologies LLC

Renaissance Technologies LLC reduced its stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 22.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,689 shares of the company's stock after selling 2,209 shares during the period. Renaissance Technologies LLC owned approximately 0.14% of Nutex Health worth $244,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in NUTX. Russell Investments Group Ltd. purchased a new stake in shares of Nutex Health in the fourth quarter worth about $672,000. World Investment Advisors acquired a new stake in Nutex Health in the fourth quarter valued at approximately $217,000. Geode Capital Management LLC raised its stake in shares of Nutex Health by 12.6% during the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after purchasing an additional 3,826 shares during the period. American Century Companies Inc. acquired a new position in shares of Nutex Health during the fourth quarter worth $1,362,000. Finally, Essex Investment Management Co. LLC grew its holdings in Nutex Health by 45.4% during the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Stock Up 0.0%

NASDAQ NUTX traded up $0.04 during mid-day trading on Friday, reaching $120.73. 57,988 shares of the company's stock traded hands, compared to its average volume of 61,930. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. Nutex Health Inc. has a 1-year low of $4.16 and a 1-year high of $152.51. The company has a fifty day simple moving average of $91.15 and a 200-day simple moving average of $57.22. The company has a market cap of $667.40 million, a price-to-earnings ratio of -12.86 and a beta of -0.10.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating the consensus estimate of ($0.09) by $11.21. The company had revenue of $81.30 million during the quarter, compared to analysts' expectations of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Analysts Set New Price Targets

Separately, Maxim Group boosted their price objective on shares of Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates bought 1,000 shares of Nutex Health stock in a transaction on Tuesday, April 8th. The shares were bought at an average price of $81.81 per share, with a total value of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. This represents a 25.72% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 38.52% of the stock is owned by company insiders.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.